Literature DB >> 11044448

Characterization of the subunit structure of the catalytically active type I iodothyronine deiodinase.

J L Leonard1, T J Visser, D M Leonard.   

Abstract

Type I iodothyronine deiodinase is a approximately 50-kDa, integral membrane protein that catalyzes the outer ring deiodination of thyroxine. Despite the identification and cloning of a 27-kDa selenoprotein with the catalytic properties of the type I enzyme, the composition and the physical nature of the active deiodinase are unknown. In this report, we use a molecular approach to determine holoenzyme composition, the role of the membrane anchor on enzyme assembly, and the contribution of individual 27-kDa subunits to catalysis. Overexpression of an immunologically unique rat 27-kDa protein in LLC-PK1 cells that contain abundant catalytically active 27-kDa selenoprotein decreased deiodination by approximately 50%, and > 95% of the LLC-PK1 derived 27-kDa selenoprotein was specifically immune precipitated by the anti-rat enzyme antibody. The hybrid enzyme had a molecular mass of 54 kDa and an s(20,w) of approximately 3.5 S indicating that every native 27-kDa selenoprotein partnered with an inert rat 27-kDa subunit in a homodimer. Enzyme assembly did not depend on the presence of the N-terminal membrane anchor of the 27-kDa subunit. Direct visualization of the deiodinase dimer showed that the holoenzyme was sorted to the basolateral plasma membrane of the renal epithelial cell.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044448     DOI: 10.1074/jbc.M006973200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  The thyroid hormone-inactivating deiodinase functions as a homodimer.

Authors:  G D Vivek Sagar; Balázs Gereben; Isabelle Callebaut; Jean-Paul Mornon; Anikó Zeöld; Cyntia Curcio-Morelli; John W Harney; Cristina Luongo; Michelle A Mulcahey; P Reed Larsen; Stephen A Huang; Antonio C Bianco
Journal:  Mol Endocrinol       Date:  2008-03-20

Review 2.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

Review 3.  Type 2 deiodinase at the crossroads of thyroid hormone action.

Authors:  Rafael Arrojo E Drigo; Antonio C Bianco
Journal:  Int J Biochem Cell Biol       Date:  2011-06-12       Impact factor: 5.085

Review 4.  Deiodinases: implications of the local control of thyroid hormone action.

Authors:  Antonio C Bianco; Brian W Kim
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

5.  Catalysis leads to posttranslational inactivation of the type 1 deiodinase and alters its conformation.

Authors:  Bo Zhu; Ashutosh Shrivastava; Cristina Luongo; Ting Chen; John W Harney; Alessandro Marsili; Thuy-Van Tran; Anulika Bhadouria; Radhika Mopala; Amanda I Steen; P Reed Larsen; Ann Marie Zavacki
Journal:  J Endocrinol       Date:  2012-04-27       Impact factor: 4.286

Review 6.  Selenium. Role of the essential metalloid in health.

Authors:  Suguru Kurokawa; Marla J Berry
Journal:  Met Ions Life Sci       Date:  2013

7.  Secondary structure propensity and chirality of the amyloidophilic peptide p5 and its analogues impacts ligand binding - In vitro characterization.

Authors:  Jonathan S Wall; Angela Williams; Craig Wooliver; Emily B Martin; Xiaolin Cheng; R Eric Heidel; Stephen J Kennel
Journal:  Biochem Biophys Rep       Date:  2016-08-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.